Vident Advisory’s Smith & Wesson SWBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$326K Sell
21,661
-221
-1% -$3.32K ﹤0.01% 1581
2026
Q1
$314K Sell
21,882
-86
-0.4% -$1.04K ﹤0.01% 1484
2025
Q4
$217K Sell
21,968
-7,147
-25% -$69K ﹤0.01% 1523
2025
Q3
$286K Sell
29,115
-9,538
-25% -$81.4K ﹤0.01% 1421
2025
Q2
$336K Sell
38,653
-5,994
-13% -$56.8K ﹤0.01% 1253
2025
Q1
$416K Sell
44,647
-6,277
-12% -$64.7K 0.01% 1129
2024
Q4
$515K Buy
50,924
+19,017
+60% +$238K 0.01% 928
2024
Q3
$414K Sell
31,907
-23,082
-42% -$333K 0.01% 1022
2024
Q2
$789K Buy
+54,989
New +$903K 0.02% 684
2024
Q1
Sell
-17,779
Closed -$241K 1409
2023
Q4
$241K Buy
+17,779
New +$245K 0.01% 1123

Other funds holding SWBI

Vident Advisory's SWBI Position: Q2 2026 in Review

Vident Advisory reduced its Smith & Wesson (SWBI) stake by 1% in Q2 2026, selling an estimated $3.32K and leaving 21,661 shares worth $326K. The position accounts for ﹤0.01% of the portfolio, ranked #1581.

Vident Advisory first reported a position in SWBI in Q4 2023 and has held it in 10 quarters since. The position peaked at $789K in Q2 2024. 200 funds tracked by Wall St. Rank hold SWBI as of Q2 2026.

  • Vident Advisory held 21,661 shares of Smith & Wesson worth $326K as of Q2 2026.
  • Vident Advisory sold 221 Smith & Wesson shares in Q2 2026, an estimated $3.32K.
  • Smith & Wesson made up ﹤0.01% of Vident Advisory's portfolio in Q2 2026, its #1581 holding.
  • Vident Advisory first reported a position in Smith & Wesson in Q4 2023 and has held it in 10 quarters since.
  • Vident Advisory's Smith & Wesson position peaked at $789K in Q2 2024.
  • 200 funds tracked by Wall St. Rank held Smith & Wesson as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.